Sulisobenzone Safety: Cleared in Europe, Open in the US
Last updated September 22, 2026
Cleared at up to 5% by the EU's safety committee in 2024, yet the FDA has never had the absorption data it asked for.
Sulisobenzone (benzophenone-4) is a sulfonated derivative of oxybenzone designed for water-based formulations. Europe's safety committee assessed it as a suspected endocrine disruptor and cleared it at up to 5% in 2024; the FDA has never had the absorption data it asked for, and its proposal to treat sulisobenzone as Category III is still unfinalized.
⚠️ Two Regulators, Two Answers
Do not read sulisobenzone as "oxybenzone by another name." The EU's 2024 review found no indications of endocrine activity for benzophenone-4 and judged it safe at up to 5%. What is genuinely missing is US-style absorption data: no maximal-usage trial has measured how much of it reaches the bloodstream.
Is Sulisobenzone Safe? The Short Answer
Two regulators have looked at benzophenone-4 recently and given two different kinds of answer.
- European Union — safe at up to 5%. The Scientific Committee on Consumer Safety assessed it as a suspected endocrine disruptor and concluded, in a final opinion adopted on 27 March 2024, that "benzophenone-4 is safe when used as UV filter up to a maximum concentration of 5% in sunscreen, face and hand cream, all leave-on and rinse-off products (total dermal aggregate), lipstick, sunscreen propellant spray and pump spray." On the specific question it was asked, the committee recorded "no indications of endocrine activity", and found benzophenone-4 not phototoxic, not photosensitising, not photomutagenic, with "no in vitro genotoxic potential" and a very low risk of sensitisation in humans. It noted no carcinogenicity data.
- United States — still undecided. The FDA has proposed Category III for sulisobenzone: "The public record does not contain sufficient data to support a positive GRASE determination for … sulisobenzone … at this time." The 2021 proposed order that replaced the 2019 rulemaking proposes requirements "substantively the same" as the 2019 rule, with scientific discussions that "are generally the same" — and neither has been finalized, so sulisobenzone remains legal at up to 10%.
The US gap is specific and it is about absorption. Sulisobenzone has been studied in laboratory skin-penetration work — the FDA records that those studies show it permeating into the epidermis and dermis, with the vehicle and companion actives able to increase that penetration, and the EU's review put the figure at 0.20% ± 0.13% of an applied dose in a human-skin test. What does not exist is the other half: of the ten filters with the biggest gaps, only homosalate, octinoxate and octisalate "appear to have been evaluated in human absorption studies," and none of the ten has been through an adequate maximal-usage trial. Nor was sulisobenzone covered by the deferral request the FDA received for eight ingredients.
The family resemblance is worth stating precisely. Benzophenone-4 is benzophenone-3 — oxybenzone — with a sulfonic acid group bolted on to make it water-soluble. That is a reason the EU put it on its endocrine-disruptor priority list; it is not a finding. The review that followed did not carry oxybenzone's problems across, sulisobenzone has its own approval and its own limits, and reef bans written against oxybenzone do not name it.
Chemical Properties and UV Protection
Sulisobenzone is benzophenone-4, created by adding a sulfonic acid group to the benzophenone structure. Approved at up to 10% concentration in the US, it's designed for water-based and beach-resistant formulations.
UV Absorption Spectrum
Protection profile similar to oxybenzone:
- Absorption maximum at 288 nm (UVB), per the EU's 2024 safety review
- Absorbs into the shorter UVA (UVA II) range as well
- Requires high concentrations for efficacy
Water Solubility Implications
The sulfonic acid group creates unique properties:
- Enables clear, water-based formulations
- May enhance skin penetration
- Increases environmental mobility
- Washes off more readily, reducing protection
Systemic Absorption Concerns
While not included in FDA absorption studies, structural analysis suggests:
- Enhanced penetration: Water solubility may increase dermal absorption
- Ionic nature: Sulfonate group could facilitate cellular uptake
- Systemic distribution: Water solubility enables wider tissue distribution
- Renal excretion: May accumulate in kidneys during elimination
Structural Similarity to Oxybenzone
Oxybenzone shows the highest absorption of any filter the FDA has tested — over 400 times its 0.5 ng/mL threshold. Sulisobenzone has never been put through the same trial, so no comparable figure exists for it. The in vitro human-skin work the EU relied on found about 0.20% of an applied dose crossing the skin, which does not support assuming oxybenzone-like exposure.
Endocrine Disruption Potential
Limited specific research exists, but benzophenone structure predicts:
- Estrogenic activity similar to oxybenzone
- Anti-androgenic effects
- Thyroid hormone interference
- Potential reproductive impacts
Water solubility may alter tissue distribution compared to oxybenzone, potentially affecting different organ systems or showing different accumulation patterns.
Environmental Concerns
Enhanced Environmental Mobility
Sulisobenzone's water solubility creates greater environmental risks:
- Readily washes off swimmers into water
- Highly mobile in aquatic systems
- Difficult to remove in wastewater treatment
- May contaminate drinking water sources
- Potentially higher bioavailability to aquatic organisms
Marine Toxicity
While less studied than oxybenzone, sulisobenzone likely shares coral toxicity concerns:
- Same benzophenone core structure
- Enhanced water solubility increases exposure
- May be included in future reef-safe bans
Limited Market Presence
Sulisobenzone usage remains minimal:
- Rarely used in US products
- Not approved in many countries
- Sometimes in hair care products with SPF
- Occasionally in water-resistant formulas
Manufacturers avoid sulisobenzone due to:
- Association with problematic benzophenones
- Consumer awareness of oxybenzone risks
- Availability of better alternatives
- Formulation challenges
Regulatory Status
United States: Approved at up to 10% concentration. FDA has not determined GRASE status, lacking sufficient safety data.
European Union: Approved at up to 5% (acid or salts).
Global perspective: Limited international approval and usage.
Unique Risks of Water Solubility
Sulisobenzone's water solubility creates distinct concerns:
For Human Health
- May penetrate skin more readily than oil-soluble filters
- Could reach systemic circulation faster
- Different organ distribution than lipophilic compounds
- Potential kidney accumulation during excretion
For Environment
- Immediate release into water bodies
- Spreads rapidly through aquatic ecosystems
- Cannot be contained or filtered easily
- May contaminate groundwater
Comparison to Oxybenzone
| Property | Oxybenzone | Sulisobenzone |
|---|---|---|
| Solubility | Oil-soluble | Water-soluble |
| Environmental mobility | Moderate | High |
| Wash-off rate | Moderate | High |
| Absorption data | Extensive (very high) | Limited |
| Reef bans | Multiple locations | Not yet targeted |
Recommendations
Given structural similarity to oxybenzone and unique water-solubility risks:
- Avoid sulisobenzone-containing products: Benzophenone risks plus water-solubility concerns
- Choose mineral alternatives: Provide protection without absorption or environmental mobility
- Be cautious with water-based SPF products: May contain sulisobenzone or similar compounds
- Check hair care products: Sometimes hidden in leave-in treatments with SPF
Sulisobenzone combines the worst aspects of chemical sunscreens: the benzophenone structure associated with high absorption and endocrine disruption, plus water solubility that enhances environmental contamination and potentially increases bioavailability. While specific studies are limited, the structural relationship to oxybenzone - now banned in multiple jurisdictions - suggests similar safety concerns. The added water solubility creates unique risks for both human health and environmental contamination. Consumers should avoid this ingredient, particularly given the availability of safer, more effective alternatives.
Recommended: EltaMD UV Pure SPF 47 — a sulisobenzone-free alternative — 100% mineral, water resistant
Frequently Asked Questions
Is sulisobenzone safe?
Regulators are split. The EU's Scientific Committee on Consumer Safety assessed benzophenone-4 as a suspected endocrine disruptor and concluded on 27 March 2024 that it "is safe when used as UV filter up to a maximum concentration of 5% in sunscreen, face and hand cream, all leave-on and rinse-off products (total dermal aggregate), lipstick, sunscreen propellant spray and pump spray" — recording no indications of endocrine activity. The FDA has not reached a conclusion: it has proposed Category III for sulisobenzone, and sulisobenzone was not among the three filters it said appeared to have been evaluated in human absorption studies. So it is cleared in Europe and unproven in the US.
What is benzophenone-4?
Benzophenone-4 is the cosmetic-ingredient name for sulisobenzone. It is the same substance, listed as sulisobenzone on a US sunscreen's Drug Facts panel and as benzophenone-4 in an INCI ingredient list. Its sodium salt is benzophenone-5.
Is sulisobenzone the same as oxybenzone?
No. Oxybenzone is benzophenone-3; sulisobenzone is benzophenone-4, the same core structure with a sulfonic acid group added to make it water-soluble. They are separate ingredients with separate approvals, and reef bans written against oxybenzone do not name sulisobenzone.
Why is sulisobenzone used in sunscreen?
Because it dissolves in water. Most UV filters are oil-soluble, so a water-soluble one lets formulators build clear, light, non-greasy products and hair or scalp formulas. It absorbs UVB and the short end of UVA, and is permitted in the US at up to 10% and in the EU at up to 5%.